Valuation: Monogram Technologies Inc.

Market Cap 244M 211M 198M 181M 340M 23.27B 345M 2.33B 911M 11.65B 915M 895M 38.85B P/E 2023
-5.61x
P/E 2024 -4.73x
Enterprise Value 228M 198M 186M 169M 319M 21.8B 324M 2.19B 853M 10.92B 858M 839M 36.41B EV / Sales 2023
257,522,925x
EV / Sales 2024 -
Free-Float
64.74%
Yield 2023 *
-
Yield 2024 -

Last Transcript: Monogram Technologies Inc.

1 year 5.27
Extreme 5.27
6.42
3 years 1.53
Extreme 1.53
6.42
5 years 1.53
Extreme 1.53
48.99
10 years 1.53
Extreme 1.53
48.99
Date Insider Type Main position Quantity % Market Cap.
07/10/25 Issuer sale

Chief Financial Officer

411,385 1.0125%
07/10/25 Issuer sale

Chief Executive Officer

5,566,330 13.6993%
07/10/25 Issuer sale

Director

40,000 0.0984%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-.--%+12.15%+23.20% 244M
-1.76%+1.08%-9.99%+20.91% 131B
-0.70%-1.48%-18.96%-0.86% 12.55B
+1.51%+10.80%+106.40%+154.67% 11.17B
-0.62%+0.71%-44.45%-67.34% 4.62B
-0.40%+4.55%-26.83%+43.11% 2.74B
-0.14%-1.17%-33.38%-76.03% 1.68B
+0.43%+2.71%-22.25%-11.67% 1.69B
+0.48%+2.30%-33.07%-33.76% 1.66B
Average -0.34%+1.24%-7.82%+5.80% 18.58B
Weighted average by Cap. -1.35%+1.58%-4.67%+24.29%

Financials

2023 2024
Net sales 0.36 0.32 0.3 0.27 0.51 34.84 0.52 3.49 1.36 17.44 1.37 1.34 58.17 -
Net income -13.75M -11.91M -11.17M -10.18M -19.16M -1.31B -19.47M -132M -51.34M -657M -51.6M -50.49M -2.19B -16.33M -14.15M -13.27M -12.1M -22.76M -1.56B -23.13M -156M -60.99M -780M -61.3M -59.97M -2.6B
Net Debt -13.1M -11.35M -10.64M -9.7M -18.26M -1.25B -18.55M -125M -48.92M -626M -49.17M -48.11M -2.09B -15.33M -13.28M -12.45M -11.36M -21.37M -1.46B -21.71M -147M -57.25M -732M -57.54M -56.29M -2.44B
Logo Monogram Technologies Inc.
Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.
Employees
-
  1. Stock Market
  2. Stocks
  3. MGRM Stock